0001127602-20-031780.txt : 20201217 0001127602-20-031780.hdr.sgml : 20201217 20201217162055 ACCESSION NUMBER: 0001127602-20-031780 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201215 FILED AS OF DATE: 20201217 DATE AS OF CHANGE: 20201217 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Stonehouse Jon P CENTRAL INDEX KEY: 0001385496 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23186 FILM NUMBER: 201396359 MAIL ADDRESS: STREET 1: 2190 PARKWAY LAKE DR CITY: BIRMINGHAM STATE: AL ZIP: 35244 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOCRYST PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000882796 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 621413174 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 BUSINESS PHONE: 919-859-1302 MAIL ADDRESS: STREET 1: 4505 EMPEROR BOULEVARD STREET 2: SUITE 200 CITY: DURHAM STATE: NC ZIP: 27703 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2020-12-15 0000882796 BIOCRYST PHARMACEUTICALS INC BCRX 0001385496 Stonehouse Jon P 4505 EMPEROR BLVD. SUITE 200 DURHAM NC 27703 1 1 President & CEO Common Stock 2020-12-15 4 M 0 134278 4.15 A 918364 D Common Stock 2020-12-15 4 S 0 134278 8.32 D 784086 D Emp. Stock Option (Right to Buy) 4.15 2020-12-15 4 M 0 134278 0 D 2012-03-01 2021-03-01 Common Stock 134278 1 D Emp. Stock Option (Right to Buy) 8.31 2020-12-15 4 A 0 870000 0 A 2021-12-15 2030-12-15 Common Stock 870000 870000 D This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 11, 2020. The price in column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $8.18 to $8.57. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Annual Employee Option Grant becomes exercisable at the rate of 25% on each of the first, second, third and fourth anniversaries of the date of grant. /s/ Alane P. Barnes, by power of attorney 2020-12-17